0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Postbiotics CDMO Service Market Research Report 2026
Published Date: 2026-01-23
|
Report Code: QYRE-Auto-30L18301
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Postbiotics CDMO Service Market Research Report 2024
BUY CHAPTERS

Global Postbiotics CDMO Service Market Research Report 2026

Code: QYRE-Auto-30L18301
Report
2026-01-23
Pages:110
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Postbiotics CDMO Service Market Size

The global Postbiotics CDMO Service market was valued at US$ 107 million in 2025 and is anticipated to reach US$ 198 million by 2032, at a CAGR of 9.3% from 2026 to 2032.

Postbiotics CDMO Service Market

Postbiotics CDMO Service Market

Postbiotics are inactivated microorganisms and/or bacterial components with a clear genetic background that are beneficial to the health of the host, including or excluding products of their metabolites; chemically synthesized components and viruses/bacteriophages and their products are excluded. Postbiotic products are added with postbiotic ingredients and are widely used in different fields (feed, food health, personal care, pet nutrition, etc.).CDMOs (Contract Development and Manufacturing Organizations) provide professional R&D and production services to other companies to help them bring postbiotic products to market. These organizations usually have extensive R&D experience and production capabilities to meet the needs of different customers.
The North American market for Postbiotics CDMO Service is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for Postbiotics CDMO Service is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The global market for Postbiotics CDMO Service in Medicines and Health Products is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 to 2032.
Major global companies of Postbiotics CDMO Service include ILDONG Bioscience Co., Ltd., Bioprox Healthcare, Exden, JuneYao Group (BioGrowing), dsm-firmenich (Adare Pharma Solutions), Sirio Pharma, Sacco System, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global Postbiotics CDMO Service market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Postbiotics CDMO Service. The Postbiotics CDMO Service market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Postbiotics CDMO Service market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Postbiotics CDMO Service manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Postbiotics CDMO Service Market Report

Report Metric Details
Report Name Postbiotics CDMO Service Market
Accounted market size in 2025 US$ 107 million
Forecasted market size in 2032 US$ 198 million
CAGR 9.3%
Base Year 2025
Forecasted years 2026 - 2032
Segment by Type
  • Oral Dosage Forms (Capsules And Tablets)
  • Powders and Granules
  • Liquid Preparations
Segment by Application
  • Medicines and Health Products
  • Food
  • Pet Food
  • Cosmetics
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company ILDONG Bioscience Co., Ltd., Bioprox Healthcare, Exden, JuneYao Group (BioGrowing), dsm-firmenich (Adare Pharma Solutions), Sirio Pharma, Sacco System
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
  • Chapter 3: Provides a detailed view of the competitive landscape for Postbiotics CDMO Service companies, covering revenue share, development plans, and mergers and acquisitions.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
  • Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
  • Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
  • Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
  • Chapter 12: Key findings and conclusions of the report.

FAQ for this report

How fast is Postbiotics CDMO Service Market growing?

Ans: The Postbiotics CDMO Service Market witnessing a CAGR of 9.3% during the forecast period 2026-2032.

What is the Postbiotics CDMO Service Market size in 2032?

Ans: The Postbiotics CDMO Service Market size in 2032 will be US$ 198 million.

Who are the main players in the Postbiotics CDMO Service Market report?

Ans: The main players in the Postbiotics CDMO Service Market are ILDONG Bioscience Co., Ltd., Bioprox Healthcare, Exden, JuneYao Group (BioGrowing), dsm-firmenich (Adare Pharma Solutions), Sirio Pharma, Sacco System

What are the Application segmentation covered in the Postbiotics CDMO Service Market report?

Ans: The Applications covered in the Postbiotics CDMO Service Market report are Medicines and Health Products, Food, Pet Food, Cosmetics

What are the Type segmentation covered in the Postbiotics CDMO Service Market report?

Ans: The Types covered in the Postbiotics CDMO Service Market report are Oral Dosage Forms (Capsules And Tablets), Powders and Granules, Liquid Preparations

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Postbiotics CDMO Service Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 Oral Dosage Forms (Capsules And Tablets)
1.2.3 Powders and Granules
1.2.4 Liquid Preparations
1.3 Market by Application
1.3.1 Global Postbiotics CDMO Service Market Growth by Application: 2021 vs 2025 vs 2032
1.3.2 Medicines and Health Products
1.3.3 Food
1.3.4 Pet Food
1.3.5 Cosmetics
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Postbiotics CDMO Service Market Perspective (2021–2032)
2.2 Global Postbiotics CDMO Service Growth Trends by Region
2.2.1 Global Postbiotics CDMO Service Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Postbiotics CDMO Service Historic Market Size by Region (2021–2026)
2.2.3 Postbiotics CDMO Service Forecasted Market Size by Region (2027–2032)
2.3 Postbiotics CDMO Service Market Dynamics
2.3.1 Postbiotics CDMO Service Industry Trends
2.3.2 Postbiotics CDMO Service Market Drivers
2.3.3 Postbiotics CDMO Service Market Challenges
2.3.4 Postbiotics CDMO Service Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Postbiotics CDMO Service Players by Revenue
3.1.1 Global Top Postbiotics CDMO Service Players by Revenue (2021–2026)
3.1.2 Global Postbiotics CDMO Service Revenue Market Share by Players (2021–2026)
3.2 Global Top Postbiotics CDMO Service Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Postbiotics CDMO Service Revenue
3.4 Global Postbiotics CDMO Service Market Concentration Ratio
3.4.1 Global Postbiotics CDMO Service Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Postbiotics CDMO Service Revenue in 2025
3.5 Global Key Players of Postbiotics CDMO Service Head Offices and Areas Served
3.6 Global Key Players of Postbiotics CDMO Service, Products and Applications
3.7 Global Key Players of Postbiotics CDMO Service, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 Postbiotics CDMO Service Breakdown Data by Type
4.1 Global Postbiotics CDMO Service Historic Market Size by Type (2021–2026)
4.2 Global Postbiotics CDMO Service Forecasted Market Size by Type (2027–2032)
5 Postbiotics CDMO Service Breakdown Data by Application
5.1 Global Postbiotics CDMO Service Historic Market Size by Application (2021–2026)
5.2 Global Postbiotics CDMO Service Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America Postbiotics CDMO Service Market Size (2021–2032)
6.2 North America Postbiotics CDMO Service Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Postbiotics CDMO Service Market Size by Country (2021–2026)
6.4 North America Postbiotics CDMO Service Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Postbiotics CDMO Service Market Size (2021–2032)
7.2 Europe Postbiotics CDMO Service Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Postbiotics CDMO Service Market Size by Country (2021–2026)
7.4 Europe Postbiotics CDMO Service Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Postbiotics CDMO Service Market Size (2021–2032)
8.2 Asia-Pacific Postbiotics CDMO Service Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Postbiotics CDMO Service Market Size by Region (2021–2026)
8.4 Asia-Pacific Postbiotics CDMO Service Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Postbiotics CDMO Service Market Size (2021–2032)
9.2 Latin America Postbiotics CDMO Service Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Postbiotics CDMO Service Market Size by Country (2021–2026)
9.4 Latin America Postbiotics CDMO Service Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Postbiotics CDMO Service Market Size (2021–2032)
10.2 Middle East & Africa Postbiotics CDMO Service Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Postbiotics CDMO Service Market Size by Country (2021–2026)
10.4 Middle East & Africa Postbiotics CDMO Service Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 ILDONG Bioscience Co., Ltd.
11.1.1 ILDONG Bioscience Co., Ltd. Company Details
11.1.2 ILDONG Bioscience Co., Ltd. Business Overview
11.1.3 ILDONG Bioscience Co., Ltd. Postbiotics CDMO Service Introduction
11.1.4 ILDONG Bioscience Co., Ltd. Revenue in Postbiotics CDMO Service Business (2021–2026)
11.1.5 ILDONG Bioscience Co., Ltd. Recent Development
11.2 Bioprox Healthcare
11.2.1 Bioprox Healthcare Company Details
11.2.2 Bioprox Healthcare Business Overview
11.2.3 Bioprox Healthcare Postbiotics CDMO Service Introduction
11.2.4 Bioprox Healthcare Revenue in Postbiotics CDMO Service Business (2021–2026)
11.2.5 Bioprox Healthcare Recent Development
11.3 Exden
11.3.1 Exden Company Details
11.3.2 Exden Business Overview
11.3.3 Exden Postbiotics CDMO Service Introduction
11.3.4 Exden Revenue in Postbiotics CDMO Service Business (2021–2026)
11.3.5 Exden Recent Development
11.4 JuneYao Group (BioGrowing)
11.4.1 JuneYao Group (BioGrowing) Company Details
11.4.2 JuneYao Group (BioGrowing) Business Overview
11.4.3 JuneYao Group (BioGrowing) Postbiotics CDMO Service Introduction
11.4.4 JuneYao Group (BioGrowing) Revenue in Postbiotics CDMO Service Business (2021–2026)
11.4.5 JuneYao Group (BioGrowing) Recent Development
11.5 dsm-firmenich (Adare Pharma Solutions)
11.5.1 dsm-firmenich (Adare Pharma Solutions) Company Details
11.5.2 dsm-firmenich (Adare Pharma Solutions) Business Overview
11.5.3 dsm-firmenich (Adare Pharma Solutions) Postbiotics CDMO Service Introduction
11.5.4 dsm-firmenich (Adare Pharma Solutions) Revenue in Postbiotics CDMO Service Business (2021–2026)
11.5.5 dsm-firmenich (Adare Pharma Solutions) Recent Development
11.6 Sirio Pharma
11.6.1 Sirio Pharma Company Details
11.6.2 Sirio Pharma Business Overview
11.6.3 Sirio Pharma Postbiotics CDMO Service Introduction
11.6.4 Sirio Pharma Revenue in Postbiotics CDMO Service Business (2021–2026)
11.6.5 Sirio Pharma Recent Development
11.7 Sacco System
11.7.1 Sacco System Company Details
11.7.2 Sacco System Business Overview
11.7.3 Sacco System Postbiotics CDMO Service Introduction
11.7.4 Sacco System Revenue in Postbiotics CDMO Service Business (2021–2026)
11.7.5 Sacco System Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global Postbiotics CDMO Service Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
 Table 2. Key Players of Oral Dosage Forms (Capsules And Tablets)
 Table 3. Key Players of Powders and Granules
 Table 4. Key Players of Liquid Preparations
 Table 5. Global Postbiotics CDMO Service Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
 Table 6. Global Postbiotics CDMO Service Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 7. Global Postbiotics CDMO Service Market Size by Region (US$ Million), 2021–2026
 Table 8. Global Postbiotics CDMO Service Market Share by Region (2021–2026)
 Table 9. Global Postbiotics CDMO Service Forecasted Market Size by Region (US$ Million), 2027–2032
 Table 10. Global Postbiotics CDMO Service Market Share by Region (2027–2032)
 Table 11. Postbiotics CDMO Service Market Trends
 Table 12. Postbiotics CDMO Service Market Drivers
 Table 13. Postbiotics CDMO Service Market Challenges
 Table 14. Postbiotics CDMO Service Market Restraints
 Table 15. Global Postbiotics CDMO Service Revenue by Players (US$ Million), 2021–2026
 Table 16. Global Postbiotics CDMO Service Market Share by Players (2021–2026)
 Table 17. Global Top Postbiotics CDMO Service Players by Tier (Tier 1, Tier 2, and Tier 3), based on Postbiotics CDMO Service Revenue, 2025
 Table 18. Ranking of Global Top Postbiotics CDMO Service Companies by Revenue (US$ Million) in 2025
 Table 19. Global 5 Largest Players Market Share by Postbiotics CDMO Service Revenue (CR5 and HHI), 2021–2026
 Table 20. Global Key Players of Postbiotics CDMO Service, Headquarters and Area Served
 Table 21. Global Key Players of Postbiotics CDMO Service, Products and Applications
 Table 22. Global Key Players of Postbiotics CDMO Service, Date of General Availability (GA)
 Table 23. Mergers and Acquisitions, Expansion Plans
 Table 24. Global Postbiotics CDMO Service Market Size by Type (US$ Million), 2021–2026
 Table 25. Global Postbiotics CDMO Service Revenue Market Share by Type (2021–2026)
 Table 26. Global Postbiotics CDMO Service Forecasted Market Size by Type (US$ Million), 2027–2032
 Table 27. Global Postbiotics CDMO Service Revenue Market Share by Type (2027–2032)
 Table 28. Global Postbiotics CDMO Service Market Size by Application (US$ Million), 2021–2026
 Table 29. Global Postbiotics CDMO Service Revenue Market Share by Application (2021–2026)
 Table 30. Global Postbiotics CDMO Service Forecasted Market Size by Application (US$ Million), 2027–2032
 Table 31. Global Postbiotics CDMO Service Revenue Market Share by Application (2027–2032)
 Table 32. North America Postbiotics CDMO Service Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 33. North America Postbiotics CDMO Service Market Size by Country (US$ Million), 2021–2026
 Table 34. North America Postbiotics CDMO Service Market Size by Country (US$ Million), 2027–2032
 Table 35. Europe Postbiotics CDMO Service Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 36. Europe Postbiotics CDMO Service Market Size by Country (US$ Million), 2021–2026
 Table 37. Europe Postbiotics CDMO Service Market Size by Country (US$ Million), 2027–2032
 Table 38. Asia-Pacific Postbiotics CDMO Service Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 39. Asia-Pacific Postbiotics CDMO Service Market Size by Region (US$ Million), 2021–2026
 Table 40. Asia-Pacific Postbiotics CDMO Service Market Size by Region (US$ Million), 2027–2032
 Table 41. Latin America Postbiotics CDMO Service Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 42. Latin America Postbiotics CDMO Service Market Size by Country (US$ Million), 2021–2026
 Table 43. Latin America Postbiotics CDMO Service Market Size by Country (US$ Million), 2027–2032
 Table 44. Middle East & Africa Postbiotics CDMO Service Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 45. Middle East & Africa Postbiotics CDMO Service Market Size by Country (US$ Million), 2021–2026
 Table 46. Middle East & Africa Postbiotics CDMO Service Market Size by Country (US$ Million), 2027–2032
 Table 47. ILDONG Bioscience Co., Ltd. Company Details
 Table 48. ILDONG Bioscience Co., Ltd. Business Overview
 Table 49. ILDONG Bioscience Co., Ltd. Postbiotics CDMO Service Product
 Table 50. ILDONG Bioscience Co., Ltd. Revenue in Postbiotics CDMO Service Business (US$ Million), 2021–2026
 Table 51. ILDONG Bioscience Co., Ltd. Recent Development
 Table 52. Bioprox Healthcare Company Details
 Table 53. Bioprox Healthcare Business Overview
 Table 54. Bioprox Healthcare Postbiotics CDMO Service Product
 Table 55. Bioprox Healthcare Revenue in Postbiotics CDMO Service Business (US$ Million), 2021–2026
 Table 56. Bioprox Healthcare Recent Development
 Table 57. Exden Company Details
 Table 58. Exden Business Overview
 Table 59. Exden Postbiotics CDMO Service Product
 Table 60. Exden Revenue in Postbiotics CDMO Service Business (US$ Million), 2021–2026
 Table 61. Exden Recent Development
 Table 62. JuneYao Group (BioGrowing) Company Details
 Table 63. JuneYao Group (BioGrowing) Business Overview
 Table 64. JuneYao Group (BioGrowing) Postbiotics CDMO Service Product
 Table 65. JuneYao Group (BioGrowing) Revenue in Postbiotics CDMO Service Business (US$ Million), 2021–2026
 Table 66. JuneYao Group (BioGrowing) Recent Development
 Table 67. dsm-firmenich (Adare Pharma Solutions) Company Details
 Table 68. dsm-firmenich (Adare Pharma Solutions) Business Overview
 Table 69. dsm-firmenich (Adare Pharma Solutions) Postbiotics CDMO Service Product
 Table 70. dsm-firmenich (Adare Pharma Solutions) Revenue in Postbiotics CDMO Service Business (US$ Million), 2021–2026
 Table 71. dsm-firmenich (Adare Pharma Solutions) Recent Development
 Table 72. Sirio Pharma Company Details
 Table 73. Sirio Pharma Business Overview
 Table 74. Sirio Pharma Postbiotics CDMO Service Product
 Table 75. Sirio Pharma Revenue in Postbiotics CDMO Service Business (US$ Million), 2021–2026
 Table 76. Sirio Pharma Recent Development
 Table 77. Sacco System Company Details
 Table 78. Sacco System Business Overview
 Table 79. Sacco System Postbiotics CDMO Service Product
 Table 80. Sacco System Revenue in Postbiotics CDMO Service Business (US$ Million), 2021–2026
 Table 81. Sacco System Recent Development
 Table 82. Research Programs/Design for This Report
 Table 83. Key Data Information from Secondary Sources
 Table 84. Key Data Information from Primary Sources
 Table 85. Authors List of This Report


List of Figures
 Figure 1. Postbiotics CDMO Service Picture
 Figure 2. Global Postbiotics CDMO Service Market Size Comparison by Type (US$ Million), 2021–2032
 Figure 3. Global Postbiotics CDMO Service Market Share by Type: 2025 vs 2032
 Figure 4. Oral Dosage Forms (Capsules And Tablets) Features
 Figure 5. Powders and Granules Features
 Figure 6. Liquid Preparations Features
 Figure 7. Global Postbiotics CDMO Service Market Size by Application (US$ Million), 2021–2032
 Figure 8. Global Postbiotics CDMO Service Market Share by Application: 2025 vs 2032
 Figure 9. Medicines and Health Products Case Studies
 Figure 10. Food Case Studies
 Figure 11. Pet Food Case Studies
 Figure 12. Cosmetics Case Studies
 Figure 13. Postbiotics CDMO Service Report Years Considered
 Figure 14. Global Postbiotics CDMO Service Market Size (US$ Million), Year-over-Year: 2021–2032
 Figure 15. Global Postbiotics CDMO Service Market Size, (US$ Million), 2021 vs 2025 vs 2032
 Figure 16. Global Postbiotics CDMO Service Market Share by Region: 2025 vs 2032
 Figure 17. Global Postbiotics CDMO Service Market Share by Players in 2025
 Figure 18. Global Postbiotics CDMO Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
 Figure 19. The Top 10 and 5 Players Market Share by Postbiotics CDMO Service Revenue in 2025
 Figure 20. North America Postbiotics CDMO Service Market Size YoY Growth (US$ Million), 2021–2032
 Figure 21. North America Postbiotics CDMO Service Market Share by Country (2021–2032)
 Figure 22. United States Postbiotics CDMO Service Market Size YoY Growth (US$ Million), 2021–2032
 Figure 23. Canada Postbiotics CDMO Service Market Size YoY Growth (US$ Million), 2021–2032
 Figure 24. Europe Postbiotics CDMO Service Market Size YoY Growth (US$ Million), 2021–2032
 Figure 25. Europe Postbiotics CDMO Service Market Share by Country (2021–2032)
 Figure 26. Germany Postbiotics CDMO Service Market Size YoY Growth (US$ Million), 2021–2032
 Figure 27. France Postbiotics CDMO Service Market Size YoY Growth (US$ Million), 2021–2032
 Figure 28. U.K. Postbiotics CDMO Service Market Size YoY Growth (US$ Million), 2021–2032
 Figure 29. Italy Postbiotics CDMO Service Market Size YoY Growth (US$ Million), 2021–2032
 Figure 30. Russia Postbiotics CDMO Service Market Size YoY Growth (US$ Million), 2021–2032
 Figure 31. Ireland Postbiotics CDMO Service Market Size YoY Growth (US$ Million), 2021–2032
 Figure 32. Asia-Pacific Postbiotics CDMO Service Market Size YoY Growth (US$ Million), 2021–2032
 Figure 33. Asia-Pacific Postbiotics CDMO Service Market Share by Region (2021–2032)
 Figure 34. China Postbiotics CDMO Service Market Size YoY Growth (US$ Million), 2021–2032
 Figure 35. Japan Postbiotics CDMO Service Market Size YoY Growth (US$ Million), 2021–2032
 Figure 36. South Korea Postbiotics CDMO Service Market Size YoY Growth (US$ Million), 2021–2032
 Figure 37. Southeast Asia Postbiotics CDMO Service Market Size YoY Growth (US$ Million), 2021–2032
 Figure 38. India Postbiotics CDMO Service Market Size YoY Growth (US$ Million), 2021–2032
 Figure 39. Australia & New Zealand Postbiotics CDMO Service Market Size YoY Growth (US$ Million), 2021–2032
 Figure 40. Latin America Postbiotics CDMO Service Market Size YoY Growth (US$ Million), 2021–2032
 Figure 41. Latin America Postbiotics CDMO Service Market Share by Country (2021–2032)
 Figure 42. Mexico Postbiotics CDMO Service Market Size YoY Growth (US$ Million), 2021–2032
 Figure 43. Brazil Postbiotics CDMO Service Market Size YoY Growth (US$ Million), 2021–2032
 Figure 44. Middle East & Africa Postbiotics CDMO Service Market Size YoY Growth (US$ Million), 2021–2032
 Figure 45. Middle East & Africa Postbiotics CDMO Service Market Share by Country (2021–2032)
 Figure 46. Israel Postbiotics CDMO Service Market Size YoY Growth (US$ Million), 2021–2032
 Figure 47. Saudi Arabia Postbiotics CDMO Service Market Size YoY Growth (US$ Million), 2021–2032
 Figure 48. UAE Postbiotics CDMO Service Market Size YoY Growth (US$ Million), 2021–2032
 Figure 49. ILDONG Bioscience Co., Ltd. Revenue Growth Rate in Postbiotics CDMO Service Business (2021–2026)
 Figure 50. Bioprox Healthcare Revenue Growth Rate in Postbiotics CDMO Service Business (2021–2026)
 Figure 51. Exden Revenue Growth Rate in Postbiotics CDMO Service Business (2021–2026)
 Figure 52. JuneYao Group (BioGrowing) Revenue Growth Rate in Postbiotics CDMO Service Business (2021–2026)
 Figure 53. dsm-firmenich (Adare Pharma Solutions) Revenue Growth Rate in Postbiotics CDMO Service Business (2021–2026)
 Figure 54. Sirio Pharma Revenue Growth Rate in Postbiotics CDMO Service Business (2021–2026)
 Figure 55. Sacco System Revenue Growth Rate in Postbiotics CDMO Service Business (2021–2026)
 Figure 56. Bottom-up and Top-down Approaches for This Report
 Figure 57. Data Triangulation
 Figure 58. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano Dimension